首页> 美国政府科技报告 >Evaluation of Levofloxacin Pharmacodynamics in a Mouse Model of Inhalational Bacillus anthracis

【24h】

Evaluation of Levofloxacin Pharmacodynamics in a Mouse Model of Inhalational Bacillus anthracis

机译：在吸入性炭疽杆菌的小鼠模型中评价左氧氟沙星药效学

获取原文

页面导航

著录项
相似文献
相关主题

著录项

作者
Heine, H. S. ; Byrne, W. R. ; Bassett, J. ; Miller, L. ; Drusano, G. L.;
展开▼
作者单位

展开▼
年度 2005
页码 1-33
总页数 33
原文格式 PDF
正文语种 eng
中图分类工业技术;
关键词
Pharmacokinetics; Antibiotics; Bacillus anthracis; Mice; Anatomical models; Inhalation;

机译：pharmacokinetics;antibiotics;Bacillus anthracis;mice;anatomical models;Inhalation;

相似文献

外文文献
中文文献
专利

1. Obiltoxaximab Prevents Disseminated Bacillus anthracis Infection and Improves Survival during Pre- and Postexposure Prophylaxis in Animal Models of Inhalational Anthrax [J] . Yamamoto Brent J., Shadiack Annette M., Carpenter Sarah, Antimicrobial agents and chemotherapy. . 2016,第10期

机译：在吸入性炭疽动物模型中，Obiltoxaximab预防分散的炭疽芽孢杆菌感染并改善暴露前和暴露后预防期间的存活率。
2. A recombinant 63-kDa form of Bacillus anthracis protective antigen produced in the yeast Saccharomyces cerevisiae provides protection in rabbit and primate inhalational challenge models of anthrax infection [J] . Hepler RW, Kelly R, McNeely TB, Vaccine . 2006,第10期

机译：酵母酵母中产生的重组炭疽芽孢杆菌保护性抗原63 kDa形式可为炭疽感染的兔子和灵长类动物吸入激发模型提供保护
3. A recombinant 63-kDa form of Bacillus anthracis protective antigen produced in the yeast Saccharomyces cerevisiae provides protection in rabbit and primate inhalational challenge models of anthrax infection [J] . Hepler RW, Kelly R, McNeely TB, Vaccine . 2006,第10期

机译：酵母酵母中产生的重组炭疽芽孢杆菌保护性抗原63 kDa形式可为炭疽感染的兔子和灵长类动物吸入激发模型提供保护
4. Testing and Evaluation of Nanoparticle Efficacy on E. Coli, and Bacillus Anthracis Spores [C] . Mark Sloan, Stan Farnsworth Nano Science and Technology Institute(NSTI) Nanotechnology Conference and Trade Show(NSTI Nanotech 2006) vol.1 . 2006

机译：纳米颗粒对大肠杆菌和炭疽芽孢杆菌孢子功效的测试和评估
5. The Dissection of Β-Lactam Resistance in Bacillus Anthracis, Bacillus Cereus, and Bacillus Thuringiensis [D] . Nauta, Kelsie Marie. 2021

机译：芽孢杆菌，芽孢杆菌，芽孢杆菌和芽孢杆菌的β-内酰胺抗性解剖
6. Obiltoxaximab Prevents Disseminated Bacillus anthracis Infection and Improves Survival during Pre- and Postexposure Prophylaxis in Animal Models of Inhalational Anthrax [O] . Brent J. Yamamoto, Annette M. Shadiack, Sarah Carpenter, 2016

机译：Obiltoxaximab预防吸入性炭疽动物模型中暴露前和暴露后预防过程中的炭疽芽孢杆菌感染并提高生存率。
7. Obiltoxaximab Prevents Disseminated Bacillus anthracis Infection and Improves Survival during Pre- and Postexposure Prophylaxis in Animal Models of Inhalational Anthrax [O] . Brent J. Yamamoto, Annette M. Shadiack, Sarah Carpenter, 2016

机译：obiltoxaximab可防止弥散性芽孢杆菌感染，并在吸入炭疽动物模型中预先曝光预防期间改善存活

Evaluation of Levofloxacin Pharmacodynamics in a Mouse Model of Inhalational Bacillus anthracis

著录项

相似文献

相关主题

期刊订阅